22 November 2022 : Clinical Research
Macronutrients Management for Growth in Neonates with Congenital Gastrointestinal Malformation
Timea E. Brandibur12AC, Aniko Maria Manea12AF, Abhinav Sharma
345BDE, Nilima Rajpal Kundnani 56AE*, Marius Călin Popoiu7D, Bilal Ahmad8B, Diala S. Dahdal 8DEF, Daniela Cioboata2C, Nicoleta Lungu12A, Florina Marinela Doandes12F, Eugen Radu Boia9F, Marioara D. Boia12AD
DOI: 10.12659/MSM.938106
Med Sci Monit 2022; 28:e938106
Table 1 Descriptive statistics.
| Characteristic | OverallN=51* | AtresiaN=17* | StenosisN=19* | OtherN=15* | p-value** |
|---|---|---|---|---|---|
| Sex | 0.10 | ||||
| F | 20 (39%) | 4 (24%) | 7 (37%) | 9 (60%) | |
| M | 31 (61%) | 13 (76%) | 12 (63%) | 6 (40%) | |
| Weight: baseline | 2,840 (2,315, 3,295) | 3,160 (2,400, 3,400) | 2,760 (2,165, 3,325) | 3,000 (2,275, 3,060) | 0.4 |
| Weight: discharge | 3,000 (2,595, 3,535) | 3,000 (2,750, 3,600) | 3,210 (2,260, 3,440) | 3,000 (2,620, 3,530) | 0.7 |
| Difference (weight) | 150 (25, 320) | 110 (0, 330) | 150 (50, 295) | 220 (35, 415) | 0.7 |
| LOS (days) | 7 (4, 14) | 6 (3, 14) | 6 (4, 14) | 10 (7, 14) | 0.2 |
| Gestation | 0.2 | ||||
| Pre-term | 20 (39%) | 5 (29%) | 8 (42%) | 7 (47%) | |
| IUGR | 8 (16%) | 3 (18%) | 5 (26%) | 0 (0%) | |
| Term | 23 (45%) | 9 (53%) | 6 (32%) | 8 (53%) | |
| Nutrition | 0.6 | ||||
| BM | 35 (69%) | 10 (59%) | 14 (74%) | 11 (73%) | |
| FM | 16 (31%) | 7 (41%) | 5 (26%) | 4 (27%) | |
| GR | 28 (55%) | 10 (59%) | 8 (42%) | 10 (67%) | 0.3 |
| Vomiting | 30 (59%) | 13 (76%) | 15 (79%) | 2 (13%) | <0.001 |
| Abdominal distension | 39 (76%) | 13 (76%) | 12 (63%) | 14 (93%) | 0.12 |
| * n (%); Median (IQR) ** Pearson’s Chi-squared test; Kruskal-Wallis rank sum test; Fisher’s exact test LOS – length of stay (days) IUGR – intra-uterine growth retardation; BM – breast milk; FM – formula milk; GR – gastric residuals. | |||||